Gene · 249
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional matrix vesicle replacement partially restores chemo-mechanical coupling in the aged bone niche. | Cell Rep Med | 2026 | 42462727 | PubTator, text mining | PubMed |
| Integrated Genetic and Biochemical Approach to Patients with Bone Disorders Exhibiting Low Alkaline Phosphatase. | Calcif Tissue Int | 2026 | 42457913 | PubTator, text mining | PubMed |
| Effect of calcium and magnesium ion incorporation on the osteogenic differentiation of human MSCs on SLA-treated titanium implant surfaces. | J Oral Sci | 2026 | 42457556 | PubTator, text mining | PubMed |
| ACAN-related short stature with an incidental ALPL variant: a case report. | Clin Pediatr Endocrinol | 2026 | 42441205 | PubTator, text mining | PubMed |
| Hypophosphatasia and collagen VI-related muscular dystrophy presenting with gait disturbance and recurrent fractures. | JCEM Case Rep | 2026 | 42395056 | PubTator, text mining | PubMed |
| Case Report: Cortical bone loss, impaired mineralization, and reduced adiposity contributing to chronic bone pain in SFRP4-related skeletal disease with an ALPL variant. | Front Endocrinol (Lausanne) | 2026 | 42381879 | PubTator, text mining | PubMed |
| Odonto-hypophosphatasia with Tooth Agenesis: a Case Report. | Chin J Dent Res | 2026 | 42377377 | PubTator, text mining | PubMed |
| Burden of disease in US patients with skeletal versus muscular or pain manifestations of hypophosphatasia: An analysis from the Global HPP Registry. | Bone | 2026 | 42365936 | PubTator, text mining | PubMed |
| Circadian-immune-related gene signature for lung squamous cell carcinoma: machine learning and multi-omics analysis. | Transl Cancer Res | 2026 | 42305521 | PubTator, text mining | PubMed |
| Experiences with the use of asfotase alfa in three patients with childhood-onset hypophosphatasia. | Endocrinol Diabetes Metab Case Rep | 2026 | 42297044 | PubTator, text mining | PubMed |
| Construction and validation of a diagnostic model for Kawasaki disease based on neutrophil-related genes and analysis of immune infiltration. | Transl Pediatr | 2026 | 42292614 | PubTator, text mining | PubMed |
| Impacts of genetic counseling on hypophosphatasia heterozygotes identified through carrier screening. | J Genet Couns | 2026 | 42266082 | PubTator, text mining | PubMed |
| Reciprocal Macrophage-MSC Crosstalk Drives Immunomodulatory and Regenerative Phenotypes in a Mineralized Collagen Scaffold. | J Biomed Mater Res A | 2026 | 42244308 | PubTator, text mining | PubMed |
| Osteogenesis Imperfecta Type 4 With COL1A2 c.1135G>A (p.Gly379Arg) Variant: Unmodified by Concurrent ALPL c.1559delT (p.Leu520ArgfsTer86) Carrier Status: A Case Report. | Cureus | 2026 | 42220822 | PubTator, text mining | PubMed |
| Additive manufacturing and in vitro characterization of scaffolds consisting of PCL/P2O5-free bioactive glasses composites with angiogenic and osteogenic potential. | Biomaterials | 2026 | 42202625 | PubTator, text mining | PubMed |
| Meso-Scale Modifications in Additively Manufactured Zirconia: Topographical Design and Its Influence on Cell-Material Interactions. | Bioengineering (Basel) | 2026 | 42194255 | PubTator, text mining | PubMed |
| Molecular Insights into the Synergistic Effect of Nano-Hydroxyapatite and L-PRF on Osteoporotic Osseointegration: An In Vivo Gene Expression Study. | J Funct Biomater | 2026 | 42188417 | PubTator, text mining | PubMed |
| Intrafamilial phenotypic variability in hypophosphatasia: evidence from two families and the literature. | Front Endocrinol (Lausanne) | 2026 | 42181201 | PubTator, text mining | PubMed |
| Development of bone alkaline phosphatase-specific monoclonal antibodies and immunoassay exhibiting low cross-reactivity to liver isoform. | JBMR Plus | 2026 | 42164530 | PubTator, text mining | PubMed |
| Identification of hypophosphatasia in adults with persistent hypophosphatasemia: clinical-genetic characterization and a validated diagnostic tool. | Osteoporos Int | 2026 | 42113233 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/249/papers?page=2